{"name":"Aethlon Medical","slug":"aethlon","ticker":"AEMD","exchange":"NASDAQ","domain":"aethlonmedical.com","description":"Aethlon Medical is a medical device company focused on immunotherapy and medical devices. The company's top products include its Hemopurifier device, which is designed to remove pathogens and toxins from the blood. Aethlon Medical is positioned as a leader in the medical device industry, with a strong focus on developing innovative treatments for various diseases. The company's products have shown promise in clinical trials and have the potential to revolutionize the treatment of certain conditions.","hq":"San Diego, CA","founded":0,"employees":"","ceo":"Timothy Rodell, MD","sector":"Medical Devices / Immunotherapy","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$25M","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":2212000,"netIncome":-13388089,"cash":5501261,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2024"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-28","type":"earnings","headline":"Aethlon Medical Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"Aethlon Medical reported its financial results for the fourth quarter and full year 2023, with revenue of $1.2 million and a net loss of $4.3 million.","drugName":"","sentiment":"neutral"},{"date":"2023-09-12","type":"deal","headline":"Aethlon Medical Announces Collaboration with University of California, San Diego","summary":"Aethlon Medical announced a collaboration with the University of California, San Diego to develop new treatments for various diseases.","drugName":"","sentiment":"positive"}],"realNews":[{"date":"2026-03-17","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxOWFpYWWlQOHNVZTFZdXBHZWZXaXFhaEJkTVZNRkFveFQ1TnU0aUtfM0VUcEtYMDJIMThLTDBKemlRcWR3aHJ4V3V0UTN3QXZZelRHRk82Y2x2SnlMeVpaMm1Ud1RNS2ctX2c1MzhiWTJia0hudkI0OWxXSFkwWkhOTV8zbjJkTUE4Nk1wN1JISVdRSUV5R2luNjJfTlB3VFNjUmZ6MnBRZVJjSUw3OGQwSHlqc2FyWHM4MTdFZWdB?oc=5","date":"2026-03-13","type":"pipeline","source":"Investing News Network","summary":"Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing - Investing News Network","headline":"Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPMk9xSk5lZzYwUkFqbHk1cDJxUW84a2RFMHppM2ltNEpRaTRqc2FkanVNNFlWSHU3WDRjNGxiTzc2bnVXd25UOHB0YWNrUlRULVNQSXpPTE03d2k3dHJvQTNKdWg4cnZES2dlZE5pVlh2OGpMVXo0U0ltOExDZEJxd0k2WUxxZmRkOV84QmNXQTl6Mkt0VTJ6ZmNhTzZ3YUFpa3A1b3ZVTDVPaldyS0d6MkdreXh6VDQ?oc=5","date":"2026-03-12","type":"pipeline","source":"Benzinga","summary":"12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga","headline":"12 Health Care Stocks Moving In Thursday's Pre-Market Session","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPTjBOM1o4U2hfamFLS3dCcVQ2cW5EbmI3Y2JEMm83VnhQWXdNRk1EZ0NyZkU3LURQZDVNdWxIMWFTWUROUi0xLUd0OUlTY0JnWEpMUUZrUmQ5cW55UG11MlNvM09uQzBULWVReE9td1dIRnFnNnZ4bTdhdFhZY013NGw2aWZnQnJ6LVhLa09ic0JycWxwYy1MLWRndU5GOThBUUdRRUZ4ZjhDT2k0cVN3RnV5eGw0YVk?oc=5","date":"2026-03-12","type":"deal","source":"Stock Titan","summary":"Cancer and infection treatment developer Aethlon explores deals with Maxim - Stock Titan","headline":"Cancer and infection treatment developer Aethlon explores deals with Maxim","sentiment":"neutral"},{"date":"2026-02-23","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2026-02-12","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: FORM 10-Q FOR DEC 2025","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2026-02-12","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNODAxN242M3huOEN3akQ1bllpbWg2LVNwSnp3eGdOcHFQVUlqUUpPTWRQaDBVQjRrdVZlY0gyUUt2cFdkZzhfdzVVUDNPeXpFSEh0TnhUZnh2UkotNGhFU2VQMWhzRGUwQ0puUUdFUUJDX3BHQlpJZVBwWkY5UHdoVnJPekJ3RWlyenlOTkc2b3RDc0JvSHhrdFRRX2Zjd3BrLWIyU2JFaUJoUUJZcWpNbGw0YlBrdnBBRlYtbA?oc=5","date":"2026-02-04","type":"earnings","source":"Stock Titan","summary":"Aethlon Medical sets Feb. 12 call on fiscal Q3 results - Stock Titan","headline":"Aethlon Medical sets Feb. 12 call on fiscal Q3 results","sentiment":"neutral"},{"date":"2026-01-26","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgJBVV95cUxNU2dsVUNrUWxQVHlibG5VMGh5R2JEaEVHZmRGZHFPbndXc1lqXzlPQWl2WkZQdlF0TWpQZVJwWXFKZWFoTVhnakZmNDU5bU9EN1U5RFBJZl94azVxLUJiTnVPeUNsRjFBemxrdVduVHBZa3A5eHliNEhGRUFjZ2JhWC0yLThhM1pCNkg1Smo4T0pWVm9FSC1mMDF0MG1oRHlCUFhqay1GWXhvT0dIUGRuM0RXQk14SHUwb1J1Q09zTUJsZWRWcmlWMDJYNFhjMG85TXE3RGVUZ25WWk5WRTE1T296WjlFRlJQcUNxcHUzRlZnQ2l1aHhtQzZ1WEFST05nQ2dfYVE2Si0tR2RCU1NyOWQ1X3kxNFpHdEE?oc=5","date":"2025-07-15","type":"trial","source":"PR Newswire","summary":"Aethlon Medical, Inc. Announces Positive Data Safety Monitoring Board Review and Recommendation to Advance to Next Clinical Trial Cohort - PR Newswire","headline":"Aethlon Medical, Inc. Announces Positive Data Safety Monitoring Board Review and Recommendation to Advance to Next Clini","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiTkFVX3lxTE12QjZOVmhQdGV1WnVMMGo0allRUTVyNThaeXNqaVhVLVNzMnk2Qy0za1p6RVBtQ1VMSy1jSkd3cm9sRnNjb0F1ckZzUHl2UQ?oc=5","date":"2022-10-19","type":"pipeline","source":"Scenari Economici","summary":"Le 1001 azioni che si sono schiantate sul mercato azionario USA - Scenari Economici","headline":"Le 1001 azioni che si sono schiantate sul mercato azionario USA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTFAzdWpGSF9VMUE3TEtlTWI1QzFOTHJkNmdia1ZrclFBVDBWOXplam92X1hob3F4Tm1PZXg5Qko0bk1yaGNMbHpmaFFRWm9VX2ZheW1sUVdlaHEwT3ZiZ2tVRk90cjdTSTNpY2ZuSmJ3TC1Xd3ZINjMyd2g2cFNvTVU?oc=5","date":"2020-02-25","type":"pipeline","source":"Yahoo Finance","summary":"18 Medical Stocks To Watch Amid The Coronavirus Outbreak - Yahoo Finance","headline":"18 Medical Stocks To Watch Amid The Coronavirus Outbreak","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE82bU5ONVJLV1FHc3k0ci0ydm5pY0t3OVF2WFhUV09TUkF1dEZrMVFLdExva3dGczl2UGZkaXdLOEFuLU51MWtRdU1VQXZEVFU3STNIOTlMSkozX2JV?oc=5","date":"2018-08-31","type":"pipeline","source":"Investorideas.com","summary":"Investing ideas for biotech stocks - stock directory of pharma, telemedicine and medical tech stocks - Investorideas.com","headline":"Investing ideas for biotech stocks - stock directory of pharma, telemedicine and medical tech stocks","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["CytomX Therapeutics","Pfizer","Bristol Myers Squibb"],"therapeuticFocus":["Immunotherapy","Medical Devices"],"financials":{"source":"sec_edgar+yahoo","revenue":0,"revenuePeriod":"2024-03-31","revenueHistory":[{"value":0,"period":"2024-03-31"},{"value":574245,"period":"2023-03-31"},{"value":294165,"period":"2022-03-31"},{"value":659104,"period":"2021-03-31"},{"value":650187,"period":"2020-03-31"},{"value":229625,"period":"2019-03-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":2212000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-13388089,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":5501261,"cashHistory":[],"totalAssets":7359534,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}